AFYREN (FR:ALAFY)

:ALAFY

ALAFY

AFYREN

RESEARCH TOOLSreports

Want to see FR:ALAFY full AI Analyst Report?

AFYREN (ALAFY) Price & Analysis

1 Followers

ALAFY Stock Chart & Stats

€2.85

-€0.20(-8.37%)

At close: Jan 09 4:00 PM EST

€2.85

-€0.20(-8.37%)

Day’s Range― - ―

52-Week Range€2.07 - €3.28

Previous CloseN/A

Volume19.43K

Average Volume (3M)10.93K

Market Cap

€100.82M

Enterprise Value€37.48M

Total Cash (Recent Filing)€35.16M

Total Debt (Recent Filing)€2.42M

Price to Earnings (P/E)―

Beta0.16

Next Earnings

Sep 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.53

Shares Outstanding38,852,520

10 Day Avg. Volume15,238

30 Day Avg. Volume10,926

Financial Highlights & Ratios

PEG Ratio-0.12

Price to Book (P/B)1.22

Price to Sales (P/S)33.31

P/FCF Ratio-14.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.24

Revenue Forecast (FY)€2.90M

Bulls Say, Bears Say

Bulls Say

Proprietary Fermentation TechnologyAFYREN’s core fermentation-based process is a durable competitive asset: it targets renewable replacements for fossil and palm-derived chemicals, enabling product differentiation across specialty-chemical niches. Proprietary process knowledge supports long-term margin and customer lock-in if scaled commercially.

Diversified End-market ExposureServing multiple application sectors (food, cosmetics, pharma, industrial) reduces demand concentration risk and increases structural addressable market. Cross-market footprints enable more stable B2B revenue mix and multiple commercialization pathways for scale-up and long-term contract wins.

Low Leverage And Sizeable Equity BaseDeclining debt and low leverage provide financial flexibility to fund industrial ramp or absorb operating shortfalls without immediate refinancing. A sizeable equity base reduces insolvency risk and supports multi-month financing runway while commercial execution improves.

Bears Say

Declining Revenue TrendTwo consecutive years of double-digit revenue decline signal weakening commercial traction or post-scale demand issues. Persistent top-line contraction undermines economies of scale needed for specialty-chemical margins and raises the bar for achieving sustainable industrial throughput and contracted offtakes.

Widening Losses And Gross Loss In 2025A structural swing to gross loss indicates cost, yield, or pricing problems at scale rather than temporary SG&A issues. Widening net losses erode retained equity and make it harder to reinvest in capacity, jeopardizing the path to margin recovery and long‑term commercial viability.

Persistent Negative Operating Cash FlowContinued negative OCF and FCF mean the business is not self-funding and requires external financing or equity dilution. Ongoing cash burn constrains capital for commercial ramp, increases refinancing risk, and places long-term viability contingent on capital markets or partner funding.

ALAFY FAQ

What was AFYREN’s price range in the past 12 months?

AFYREN lowest stock price was €2.06 and its highest was €3.28 in the past 12 months.

What is AFYREN’s market cap?

AFYREN’s market cap is €100.82M.

When is AFYREN’s upcoming earnings report date?

AFYREN’s upcoming earnings report date is Sep 25, 2026 which is in 127 days.

How were AFYREN’s earnings last quarter?

AFYREN released its earnings results on Mar 31, 2026. The company reported -€0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.264.

Is AFYREN overvalued?

According to Wall Street analysts AFYREN’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AFYREN pay dividends?

AFYREN does not currently pay dividends.

What is AFYREN’s EPS estimate?

AFYREN’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AFYREN have?

AFYREN has 38,852,520 shares outstanding.

What happened to AFYREN’s price movement after its last earnings report?

AFYREN reported an EPS of -€0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.099%.

Which hedge fund is a major shareholder of AFYREN?

Currently, no hedge funds are holding shares in FR:ALAFY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AFYREN

AFYREN SAS, a sustainable chemical company, produces biomolecules derived from the recycling of non-food biomass, primarily used in human and animal nutrition, flavors and fragrances, life sciences, materials sciences, and lubricants sectors. It offers biosourced organic acids, such as acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. The company was incorporated in 2012 and is headquartered in Clermont-Ferrand, France.